Gastos De Venta Y Administración Cambio Fecha
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
CSL USD 1.23B 498M 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Grifols EUR 320.45M 12.65M 2025-12
Immunic USD 3.45M 451K 2025-12
Insmed USD 253.03M 5.56M 2026-09
Omeros USD 11.32M 2.48M 2024-09
OraSure Technologies USD 13.21M 3.29M 2025-12
Quidel USD 182.7M 7M 2026-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
United Therapeutics USD 184.1M 22.6M 2026-09